Webinar :Join Commodity Ki Paathshala on ‘Volatility in Agriculture commodities Prices- Importance of Price Risk Management and Role of Derivatives Markets’ on March 9, 5pm. Register Now!
you are here: HomeNewsBusiness

Coronavirus impact | Apollo Tyres CMD takes 25% pay cut, top management to take 15% hit

It cited “rapidly deteriorating market conditions caused by the COVID-19 pandemic,” as the reason

March 20, 2020 / 02:36 PM IST
Onkar Kanwar, CMD, Apollo Tyres

Onkar Kanwar, CMD, Apollo Tyres

  • bselive
  • nselive
Todays L/H

The top management of Apollo Tyres has taken voluntary pay cut taking into account impact of the coronavirus (COVID-19) pandemic on the automotive industry, the company informed the exchanges on March 20.

Chairman and Managing Director Onkar S Kanwar and Vice CMD Neeraj Kanwar have taken a pay cut of 25 percent each while the senior management will be taking a 15 percent hit in their salaries.

Track this blog for live updates on the coronavirus outbreak

"This is an incredibly difficult time for our employees and their families. We are in unchartered waters but will work together and make the necessary sacrifices to steer Apollo Tyres to overcome this period," Kanwar said.

Apart from them, in as show of solidarity, other top management have also taken 15 percent voluntary pay cut. It cited "rapidly deteriorating market conditions caused by the COVID-19 pandemic", as the reason.


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

Earlier, Interglobe Aviation, the operator of India's largest airline IndiGo, had announced a pay cut of employees due to the adverse impact of the coronavirus outbreak on its operations.

The coronavirus outbreak has smothered the growth prospects of the Indian corporate sector, already hobbled by a prolonged slowdown and disruption caused by the tardy rollout of the Goods and Services Tax.
Moneycontrol News
first published: Mar 20, 2020 02:04 pm

stay updated

Get Daily News on your Browser